Natco Pharma Ltd. (NATP)

896.35 +12.30 (+1.39%)
Close INR Disclaimer

Natco Pharma Ltd. Company Profile

Equity Type
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.
Contact Information
Banjara Hills Hyderabad,500034 India
91 40 2354 7532
91 40 2354 8243
Top Executives
Dasu Govinda Prasad 73 2014 Independent Director
Madireddi Umamaheshwarrao Naidu 72 2015 Independent Director
Sridhar Sankararaman 40 2018 Non-executive & Non-independent Director
Potluri Sivaramakrishna Prasad 63 2014 Executive VP of Corporate Engineering Services & Whole Time Director
Thallapaka Venkateswara Rao 69 2012 Independent Director
Leela Digumarti 61 2014 Independent Director
Donthineni Linga Rao 69 2015 President of Technical Affairs & Whole Time Director
Rajeev Nannapaneni 44 2005 Vice Chairman & CEO
Venkaiah Chowdary Nannapaneni 76 1981 Chairman & MD
Sreerama Murthy Gubbala 84 2000 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles